Browsing Category
Pharma Industry News
4753 posts
Business-News-Today.com section for global pharma industry news, Indian pharma sector latest news, pharma sector news today, pharmaceuticals industry news.
Newron and EA Pharma secure landmark licensing deal to advance schizophrenia treatment
In a move set to transform treatment options for patients with schizophrenia, Newron Pharmaceuticals S.p.A. (“Newron”) has entered…
Nintx secures $10m to drive breakthrough therapies harnessing Brazilian biodiversity
Nintx (Next Innovative Therapeutics), a rising star in Brazil’s biotechnology sector, has successfully raised $10 million in a…
BrightPath Bio, Cellistic join forces to advance iPSC-derived CAR-NKT cell therapy for multiple myeloma
BrightPath Bio and Cellistic have entered into a collaboration aimed at advancing iPSC-derived CAR-NKT cell therapy. This partnership…
Galderma’s Nemluvio gains FDA nod for moderate-to-severe atopic dermatitis
Galderma has achieved a significant milestone with the U.S. Food and Drug Administration’s (FDA) approval of Nemluvio (nemolizumab)…
Swiss biotech company Noema Pharma secures CHF130m to advance CNS therapies
Basel, Switzerland-based Noema Pharma, a clinical-stage biotech company, has announced the successful close of its Series B financing…
Novo Nordisk set to finalize $11bn acquisition of Catalent manufacturing sites
Novo Nordisk is set to finalise its acquisition of three Catalent manufacturing sites, marking a pivotal step in…
AbbVie to expand immunology pipeline with Nimble Therapeutics acquisition
In a significant move to solidify its presence in immunology, AbbVie has announced the acquisition of Nimble Therapeutics,…
Inovio Pharmaceuticals faces tumultuous stock reaction to $30m offering
Inovio Pharmaceuticals, a biotechnology company specialising in DNA medicines, witnessed a sharp decline in its stock value following…
Lupin acquires diabetes trademarks from Boehringer Ingelheim to bolster treatment portfolio
Lupin Limited, a global pharmaceutical leader based in Mumbai, has announced the acquisition of three anti-diabetes trademarks—GIBTULIO, GIBTULIO…
Rakovina Therapeutics’ private placement fuels DNA-damage response therapies
Rakovina Therapeutics Inc. (TSX-V: RKV), a biopharmaceutical company pioneering innovative cancer therapies through advancements in DNA-damage response technologies,…